The activity of the MAPK signaling pathway, comprising the cascade of RAS (Rat sarcoma oncogene)/RAF (v-Raf murine sarcoma viral oncogene homolog B)/MEK (mitogen-activated protein kinase kinase)/ERK, is very frequently altered in melanoma by somatic mutations [22]. Here, WNK2 is linked to melanoma.